Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
暂无分享,去创建一个
Robert B. Russell | Pablo Tamayo | Olivier Harismendy | Francesco Raimondi | Victoria Wu | P. Tamayo | O. Harismendy | R. Russell | Francesco Raimondi | J. Gutkind | A. Inoue | Joshua Chiou | Huwate Yeerna | V. Wu | N. Nohata | J. Silvio Gutkind | Nijiro Nohata | Joshua Chiou | Huwate Yeerna | Asuka Inoue | Victoria H. Wu | R. Russell
[1] P. Mathur,et al. Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities. , 2015, Biochimica et biophysica acta.
[2] E. Hirsch,et al. PI3Kγ mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis. , 2011, Cancer cell.
[3] Hans Clevers,et al. EVIEWS IN BASIC AND CLINICAL ASTROENTEROLOGY , 2008 .
[4] Abanoub A. Gad,et al. The Emerging Role of Adhesion GPCRs in Cancer. , 2020, ACS pharmacology & translational science.
[5] Dereje D. Jima,et al. The genetic landscape of mutations in Burkitt lymphoma , 2012, Nature Genetics.
[6] Li Zhang,et al. Activation of PGE2/EP2 and PGE2/EP4 signaling pathways positively regulate the level of PD-1 in infiltrating CD8+ T cells in patients with lung cancer. , 2017, Oncology letters.
[7] Y Sheng,et al. Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration , 2009, Oncogene.
[8] G. Schulte,et al. Frizzleds as GPCRs - More Conventional Than We Thought! , 2018, Trends in pharmacological sciences.
[9] L. F. Kolakowski. GCRDb: a G-protein-coupled receptor database. , 1994, Receptors & channels.
[10] Kolakowski Lf. GCRDB: A G-PROTEIN-COUPLED RECEPTOR DATABASE , 1994 .
[11] G. Frampton,et al. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers , 2018, Cancer.
[12] R. Anderson,et al. Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils. , 2000, Biochemical pharmacology.
[13] C. Der,et al. Rho GTPase-dependent transformation by G protein-coupled receptors , 2001, Oncogene.
[14] R. Scolyer,et al. Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine , 2008, Clinical Cancer Research.
[15] Q. Gu,et al. Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.
[16] P. McDonald,et al. GPCRs: Emerging anti-cancer drug targets. , 2018, Cellular signalling.
[17] S. Rasmussen,et al. The structure and function of G-protein-coupled receptors , 2009, Nature.
[18] J. Cooper,et al. Targeting nucleotide exchange to inhibit constitutively active G protein α subunits in cancer cells , 2018, Science Signaling.
[19] Ellen T. Gelfand,et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies , 2014, Scientific Data.
[20] J. Werner,et al. β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. , 2018, Cancer cell.
[21] Adrien B. Larsen,et al. Loss of signaling via Gα13 in germinal center B cell-derived lymphoma , 2014, Nature.
[22] S. Offermanns. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. , 2014, Annual review of pharmacology and toxicology.
[23] S. Seshagiri,et al. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer , 2013, Nature Reviews Cancer.
[24] W. Xue,et al. Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status , 2016, Stem cell reports.
[25] J. Gutkind,et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. , 2003, Cancer cell.
[26] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[27] J. Linden,et al. Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.
[28] C. López-Otín,et al. Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.
[29] P. Sharma,et al. The future of immune checkpoint therapy , 2015, Science.
[30] J. Chun,et al. Lysophospholipid receptors: signaling and biology. , 2004, Annual review of biochemistry.
[31] M. Dewhirst,et al. The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Blackmore,et al. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. , 1992, British journal of cancer.
[33] C. Hsiung,et al. G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization. , 2009, Cancer research.
[34] Weiqi Wang,et al. Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.
[35] H. Moch,et al. Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.
[36] J. Gutkind,et al. Novel insights into G protein and G protein-coupled receptor signaling in cancer. , 2014, Current opinion in cell biology.
[37] R. Stevens,et al. How Ligands Illuminate GPCR Molecular Pharmacology , 2017, Cell.
[38] W. El-Deiry,et al. Role of Dopamine Receptors in the Anticancer Activity of ONC201 , 2017, Neoplasia.
[39] M. Smyth,et al. Targeting cancer-derived adenosine: new therapeutic approaches. , 2014, Cancer discovery.
[40] E. Hawk,et al. Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention , 2011, Cancer Prevention Research.
[41] M. Fresno,et al. Prostaglandin E2 and T cells: friends or foes? , 2011, Immunology and cell biology.
[42] Tudor I. Oprea,et al. A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.
[43] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[44] J. Utikal,et al. CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma , 2017, Cancer Immunology, Immunotherapy.
[45] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[46] T. Schumacher,et al. T Cell Dysfunction in Cancer. , 2018, Cancer cell.
[47] R. Monteiro,et al. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines. , 2012, Biochemical and biophysical research communications.
[48] P. Tamayo,et al. A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. , 2019, Cancer cell.
[49] J. Gutkind,et al. The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Kolb,et al. Direct targeting of Gαq and Gα11 oncoproteins in cancer cells , 2019, Science Signaling.
[51] T. Šarić,et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. , 2006, Blood.
[52] S. A. K. Rasheed,et al. GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers , 2017, Oncogene.
[53] H. Tomita,et al. Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling. , 2017, Cancer cell.
[54] S. Saccani,et al. Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.
[55] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[56] Mónica Sala-Valdés,et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non‐Hodgkin lymphomas with widespread nodular dissemination , 2004, Journal of leukocyte biology.
[57] Y. Lou,et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges , 2018, Journal of Hematology & Oncology.
[58] K. Druey,et al. Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.
[59] S. Narumiya,et al. Roles of a prostaglandin E‐type receptor, EP3, in upregulation of matrix metalloproteinase‐9 and vascular endothelial growth factor during enhancement of tumor metastasis , 2009, Cancer science.
[60] Jiewei Chen,et al. GNA13 as a prognostic factor and mediator of gastric cancer progression , 2015, Oncotarget.
[61] Melody A. Swartz,et al. Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.
[62] A. Heguy,et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth , 2016, Oncogenesis.
[63] Weiping Zou,et al. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy , 2017, Nature Reviews Immunology.
[64] S. Powers,et al. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers , 2004, Oncogene.
[65] L. Wood,et al. GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. , 2018, Gastroenterology.
[66] P. Crespo,et al. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits , 1994, Nature.
[67] J. V. Stein,et al. Chemokine control of lymphocyte trafficking: a general overview , 2005, Immunology.
[68] S. Rafii,et al. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. , 2012, Developmental cell.
[69] P. Kalinski,et al. Key role of the positive feedback between PGE2 and COX2 in the biology of myeloid-derived suppressor cells , 2012, Oncoimmunology.
[70] P. Ward,et al. Bacterial factors chemotactic for polymorphonuclear leukocytes. , 1968, The American journal of pathology.
[71] Ahmed Sadeque,et al. Identification and characterization of alternative exon usage linked glioblastoma multiforme survival , 2012, BMC Medical Genomics.
[72] Garret A. FitzGerald,et al. Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[73] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[74] J. Gutkind,et al. A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[75] K. Claffey,et al. Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.
[76] J. Lunceford,et al. IFN-&ggr;–related mRNA profile predicts clinical response to PD-1 blockade , 2017, The Journal of clinical investigation.
[77] M. Yao,et al. Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt , 2015, Clinical Cancer Research.
[78] J. Herbert,et al. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. , 1994, The Biochemical journal.
[79] A. Fukamizu,et al. Tumor and Stem Cell Biology Cancer Research S 1 P 2 , the G Protein – Coupled Receptor for Sphingosine-1-Phosphate , Negatively Regulates Tumor Angiogenesis and Tumor Growth In vivo in Mice , 2010 .
[80] M. Burdick,et al. Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer , 2004, Cancer Research.
[81] P. Darcy,et al. Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy , 2013, Oncoimmunology.
[82] E. Simpson,et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi , 2008, Nature.
[83] R. Adams,et al. G13 controls angiogenesis through regulation of VEGFR-2 expression. , 2013, Developmental cell.
[84] T. Jessell,et al. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.
[85] B. Kobilka,et al. Structure and dynamics of GPCR signaling complexes , 2018, Nature Structural & Molecular Biology.
[86] Rajiv Narayan,et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition , 2013, Nature.
[87] Ying-Hui Fu,et al. A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures , 2002, Annals of neurology.
[88] M. Rosenkilde,et al. Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor , 2005, Journal of Virology.
[89] John Q. Davies,et al. Leukocyte adhesion-GPCR EMR2 is aberrantly expressed in human breast carcinomas and is associated with patient survival. , 2011, Oncology reports.
[90] David J. Forsthoefel,et al. A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. , 2013, Molecular cell.
[91] J C Reubi,et al. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. , 1999, Cancer research.
[92] J. O'Brien,et al. Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.
[93] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[94] H. Bourne,et al. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.
[95] P. Kiberstis. Cancer and nerves: A tuf(t) partnership. , 2017, Science.
[96] G. Hortobagyi,et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. , 2004, Cancer cell.
[97] Seung‐Mo Hong,et al. Overexpression of Smoothened Activates the Sonic Hedgehog Signaling Pathway in Pancreatic Cancer–Associated Fibroblasts , 2010, Clinical Cancer Research.
[98] J. Blusztajn,et al. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. , 2003, Cancer research.
[99] Li Zhu,et al. Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells1 , 2005, The Journal of Immunology.
[100] Yin Cao,et al. Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.
[101] Shuji Ogino,et al. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.
[102] L. Désaubry,et al. Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments , 2020, Frontiers in Cardiovascular Medicine.
[103] Michelle Monje,et al. Settling a Nervous Stomach: The Neural Regulation of Enteric Cancer. , 2017, Cancer cell.
[104] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[105] A. Jemal,et al. Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[106] C. Pert,et al. High levels of intracellular bombesin characterize human small-cell lung carcinoma. , 1981, Science.
[107] Shailesh Singh,et al. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. , 2011, International journal of oncology.
[108] Lorin Crawford,et al. A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution. , 2017, Cell reports.
[109] J. Qin,et al. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer , 2018, Immunopharmacology and immunotoxicology.
[110] Z. Trajanoski,et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.
[111] M. Mino‐Kenudson,et al. Mutant GNAS drives pancreatic tumorigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism , 2018, Nature Cell Biology.
[112] M. Fresno,et al. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. , 1999, Journal of immunology.
[113] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.
[114] A. Schally,et al. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[115] S. Rafii,et al. Angiocrine functions of organ-specific endothelial cells , 2016, Nature.
[116] L. Zon,et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis , 2007, Nature.
[117] Y. Yarden,et al. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. , 2016, Seminars in cell & developmental biology.
[118] J. Gutkind,et al. Potent Activation of RhoA by Gαq and Gq-coupled Receptors* , 2002, Journal of Biological Chemistry.
[119] Li Ding,et al. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. , 2018, Cell systems.
[120] David E. Gloriam,et al. Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.
[121] Antal Rot,et al. CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.
[122] G. Mills,et al. Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer , 2000, Annals of the New York Academy of Sciences.
[123] E. Kostenis,et al. Arrestins as rheostats of GPCR signalling , 2018, Nature Reviews Molecular Cell Biology.
[124] M. Brann,et al. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[125] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[126] Shailesh Singh,et al. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. , 2011, International journal of oncology.
[127] P. Casey,et al. A Role for the G12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion* , 2006, Journal of Biological Chemistry.
[128] Vincenzo De Giorgi,et al. Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study , 2017, JAMA oncology.
[129] N. Dascal,et al. The Roles of Gβγ and Gα in Gating and Regulation of GIRK Channels. , 2015, International review of neurobiology.
[130] D. Carbone,et al. Adenosine receptors in regulation of dendritic cell differentiation and function. , 2008, Blood.
[131] J. Gutkind,et al. Viral hijacking of G-protein-coupled-receptor signalling networks , 2004, Nature Reviews Molecular Cell Biology.
[132] R. Proia,et al. The role of G protein-coupled receptors in lymphoid malignancies. , 2017, Cellular signalling.
[133] R. Russell,et al. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm , 2019, Oncogene.
[134] A. Aplin,et al. Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma , 2018, Molecular Cancer Research.
[135] P. Insel,et al. GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets , 2020, British journal of pharmacology.
[136] P. Wen,et al. A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma , 2017, Oncotarget.
[137] C. Rubini,et al. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. , 2006, European journal of cancer.
[138] Khalid W. Kalim,et al. Inactivating Mutations in GNA13 and RHOA in Burkitt’s Lymphoma and Diffuse Large B cell Lymphoma: A Tumor Suppressor Function for the Gα13/RhoA Axis in B Cells , 2015, Oncogene.
[139] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[140] R. Nusse,et al. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.
[141] Lei Xu,et al. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[142] A. Cerwenka,et al. Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth , 2012, The Journal of Immunology.
[143] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[144] A. Schally,et al. Presence of receptors for bombesin/gastrin‐releasing peptide and mRNA for three receptor subtypes in human prostate cancers , 2000, The Prostate.
[145] D. Waugh,et al. The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.
[146] Rob Leurs,et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis , 2006, Proceedings of the National Academy of Sciences.
[147] C. Esapa,et al. G protein and thyrotropin receptor mutations in thyroid neoplasia. , 1997, The Journal of clinical endocrinology and metabolism.
[148] G. Schultz,et al. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[149] R. Hynes,et al. GPR56 Regulates VEGF production and angiogenesis during melanoma progression. , 2011, Cancer research.
[150] E. P. Chen,et al. COX-2 and PGE2-dependent immunomodulation in breast cancer. , 2011, Prostaglandins & other lipid mediators.
[151] Arthur Christopoulos,et al. Endogenous Allosteric Modulators of G Protein–Coupled Receptors , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[152] L. Antonioli,et al. Anti-CD73 in cancer immunotherapy: awakening new opportunities. , 2016, Trends in cancer.
[153] T. Manabe,et al. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes , 2007, Oncogene.
[154] Lin Zhang,et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.
[155] K. Szepesházi,et al. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists , 2000, British Journal of Cancer.
[156] R. Lefkowitz,et al. Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.
[157] D. Busch,et al. Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. , 2005, Blood.
[158] C. Dahlgren,et al. Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions. , 2020, ACS pharmacology & translational science.
[159] A. Ohta. A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment , 2016, Front. Immunol..
[160] Simin Xu,et al. Hijacking GPCRs by viral pathogens and tumor. , 2016, Biochemical pharmacology.
[161] C. Orvain,et al. Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[162] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[163] O. Matsui,et al. Sphingosine-1-Phosphate, a Platelet-Derived Lysophospholipid Mediator, Negatively Regulates Cellular Rac Activity and Cell Migration in Vascular Smooth Muscle Cells , 2002, Circulation research.
[164] L. Trusolino,et al. Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation. , 2012, Cancer discovery.
[165] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[166] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[167] S. Rafii,et al. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. , 2003, Cancer cell.
[168] E. Kostenis,et al. Heterotrimeric Gq proteins as therapeutic targets? , 2020, The Journal of Biological Chemistry.
[169] B. Bastian,et al. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. , 2017, Cancer cell.
[170] M. Boutros,et al. Wnt signaling in cancer , 2016, Oncogene.
[171] C. Berking,et al. Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[172] Robert Fredriksson,et al. The GRAFS classification system of G-protein coupled receptors in comparative perspective. , 2005, General and comparative endocrinology.
[173] D. Pan,et al. The hippo signaling pathway in development and cancer. , 2010, Developmental cell.
[174] G. Tall,et al. A Comprehensive Mutagenesis Screen of the Adhesion GPCR Latrophilin-1/ADGRL1 , 2018, iScience.
[175] K. Frazer,et al. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin , 2014, Genome Medicine.
[176] J. P. Smith,et al. Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. , 1994, The American journal of physiology.
[177] H. Kotani,et al. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer , 2009, BMC Genomics.
[178] R. Strieter,et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer , 2006, The Journal of experimental medicine.
[179] Hiroshi Yokouchi,et al. GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets , 2018, Front. Pharmacol..
[180] B. Gao,et al. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines , 2006, Cancer biology & therapy.
[181] M. Babu,et al. Mechanisms of signalling and biased agonism in G protein-coupled receptors , 2018, Nature Reviews Molecular Cell Biology.
[182] M. Thompson,et al. G protein-coupled receptor mutations and human genetic disease. , 2014, Methods in molecular biology.
[183] K. Roche,et al. Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice , 2011, Proceedings of the National Academy of Sciences.
[184] J. Lunceford,et al. IFN- γ –related mRNA profile predicts clinical response to PD-1 blockade , 2017 .
[185] Eugene Y. Kim,et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.
[186] Tsuyoshi Saito,et al. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. , 2014, Human pathology.
[187] M. Wigler,et al. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains , 1986, Cell.
[188] J. Parma,et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.
[189] Olga Rudenko,et al. GPCR-Mediated Signaling of Metabolites. , 2017, Cell metabolism.
[190] T. Nishikawa,et al. Tumorigenesis and Neoplastic Progression G-Protein-Coupled Receptor GPR 49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation , 2010 .
[191] A. Maitra,et al. Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development , 2011, Science Translational Medicine.
[192] B. Ebert,et al. Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance , 2014, Nature Medicine.
[193] M. Merino,et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. , 1991, The New England journal of medicine.
[194] J. Pollard,et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages , 2015, Journal of Experimental Medicine.
[195] I. Bechmann,et al. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way , 2010, Glia.
[196] Peter W. Laird,et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer , 2018, Cell.
[197] G. Sauvageau,et al. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets , 2016, Blood Cancer Journal.
[198] Edward S. Kim,et al. Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers , 2017, Science Translational Medicine.
[199] B. Barrell,et al. Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.
[200] I. Mellman,et al. Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.
[201] Matthew D. Shirley,et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. , 2013, The New England journal of medicine.
[202] R. Russell,et al. Illuminating G-Protein-Coupling Selectivity of GPCRs , 2019, Cell.
[203] R. Abagyan,et al. Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. , 2013, Annual review of pharmacology and toxicology.
[204] Xiang-Dong Fu,et al. Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling , 2012, Cell.
[205] H. Müller-Eberhard,et al. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO , 1965, The Journal of experimental medicine.
[206] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[207] J. Werner,et al. β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. , 2018, Cancer cell.
[208] Kathleen M. Smith,et al. Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors , 2006, Cancer biology & therapy.
[209] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[210] C. Speyer,et al. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer , 2012, Breast Cancer Research and Treatment.
[211] C. Drachenberg,et al. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[212] J. Mulliken,et al. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. , 2016, American journal of human genetics.
[213] Arthur Christopoulos,et al. Structural insights into G-protein-coupled receptor allostery , 2018, Nature.
[214] Brian Barnett,et al. Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals , 2004, Cancer Research.
[215] J. Allison,et al. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. , 2018, Cancer discovery.
[216] P. Ingham,et al. Hedgehog signalling , 2016, Development.
[217] J. Gutkind,et al. G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.
[218] J. Gutkind,et al. Modular architecture and novel protein-protein interactions regulating the RGS-containing Rho guanine nucleotide exchange factors. , 2004, Methods in enzymology.
[219] Susan S. Taylor,et al. Inactivation of a Gαs-PKA tumor suppressor pathway in skin stem cells initiates basal-cell carcinogenesis , 2015, Nature Cell Biology.
[220] J. Kastrup,et al. Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1 , 2012, PloS one.
[221] R. Ransohoff. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. , 2009, Immunity.
[222] S. Narumiya,et al. Prostaglandin E Receptors* , 2007, Journal of Biological Chemistry.
[223] L. Brass,et al. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. , 2004, Molecular cancer research : MCR.
[224] Richard D. Ye,et al. The Lysophospholipid Receptor G2A Activates a Specific Combination of G Proteins and Promotes Apoptosis* , 2003, The Journal of Biological Chemistry.
[225] Kun Huang,et al. New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC , 2009, Inflammatory bowel diseases.
[226] Pier Andrea Borea,et al. Pharmacology of Adenosine Receptors: The State of the Art. , 2018, Physiological reviews.
[227] J. Gutkind,et al. Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells , 1992, Molecular and cellular biology.
[228] E. Kawasaki,et al. Two G protein oncogenes in human endocrine tumors. , 1990, Science.
[229] A. Klein-Szanto,et al. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. , 2010, Molecular cell.
[230] W. Scherbaum,et al. CD97: a dedifferentiation marker in human thyroid carcinomas. , 1997, Cancer research.
[231] Eric S. Lander,et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.
[232] G. Merlino,et al. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. , 2014, Cancer cell.
[233] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[234] P. Meltzer,et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia , 2003, Nature Genetics.
[235] Albert Zlotnik,et al. Homeostatic chemokine receptors and organ-specific metastasis , 2011, Nature Reviews Immunology.
[236] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[237] John D. Minna,et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.
[238] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[239] B. Taylor,et al. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma , 2016, Nature Genetics.
[240] Deborah S. Barkauskas,et al. A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. , 2018, Cancer research.
[241] G. Giannattasio,et al. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.
[242] G. Mills,et al. Lysophospholipids activate ovarian and breast cancer cells. , 1995, The Biochemical journal.
[243] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[244] Robert J. Lefkowitz,et al. Transduction of Receptor Signals by ß-Arrestins , 2005, Science.
[245] K. Shokat,et al. Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP , 2018, Cell.
[246] J. Powell,et al. A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy , 2015, Computational and structural biotechnology journal.
[247] Yue Zhang,et al. Efficient Yttrium(III) Chloride-Treated TiO2 Electron Transfer Layers for Performance-Improved and Hysteresis-Less Perovskite Solar Cells. , 2018, ChemSusChem.
[248] S. Coughlin,et al. How the protease thrombin talks to cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[249] M. Laburthe,et al. Protease-activated Receptor 2 in Colon Cancer , 2004, Journal of Biological Chemistry.
[250] M. Caron,et al. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.